Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 1

1(14.3%)

Phase 4

1(14.3%)

Phase 3

1(14.3%)

7Total

N/A(4)

Phase 1(1)

Phase 4(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05910736Not ApplicableActive Not Recruiting

Increasing the Feasibility, Impact, and Equity of the Medicare Annual Wellness Visit (AWV)

Role: collaborator

NCT05563415Not ApplicableActive Not Recruiting

AWV Practice Redesign Toolkit (Tailored Intervention)

Role: collaborator

NCT04664062Not ApplicableActive Not Recruiting

Comparing Home, Office, and Telehealth Induction for Medication Assisted Treatment for Opioid Use Disorder

Role: collaborator

NCT05890495Phase 4Unknown

Patient-Applied Pretreatment Analgesia for Intrauterine Device Placement

Role: collaborator

NCT02783365Not ApplicableCompleted

Improving the Management of Chronic Pain in Primary Care

Role: collaborator

NCT01290874Phase 3Completed

Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT)

Role: collaborator

NCT00996112Completed

Primary Care Management of Community-Acquired, Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Infections

Role: collaborator

NCT00164658Phase 1Completed

Evaluating Tools for Health Promotion and Disease Prevention

Role: collaborator

All 8 trials loaded